5 Top Life Science Stories for Q1 2015

Q1 is now over, and to mark the occasion, Life Science Investing News has assembled the articles that got the most traffic during the period.

Levon Resources Takes on Hepatitis B

The company announced Friday that it has entered into an arrangement agreement that will see it acquire SciVac, a private company.

Read More Feature Articles



Company News

Miraculins Closes $400,000 Private Placement

Miraculins Closes $400,000 Private Placement

Miraculins (TSXV:MOM) has closed its recently announced private placement offering for gross proceeds of $400,000. Proceeds of the offering will be used for general corporate purposes.

M Pharmaceutical Clarifies Timing for Share Consolidation

M Pharmaceutical Clarifies Timing for Share Consolidation

M Pharmaceutical (CSE:MQ) has clarified the timing of its previously announced ten to one share consolidation. Shares of the company will begin trading on a post-consolidation basis on the CSE on Friday, April 17 2015.

Read More Company News

Market News

Cancer Risk Increased by Too Many Dietary Supplements

The University of Colorado Cancer Center reported that research has surfaced showing that over-the-counter supplements may increase cancer risk if more than the daily recommended amount is taken.

Boston Hosts Heaviest Concentration of Life Science Companies

Boston Business Journal reported that Boston now hosts the heaviest concentration of life science companies in the world. Interestingly, however, the state is between third and eighth in terms of total life science job growth.

Nanoparticle Injection Could Reduce Lung Damage in Soldiers

Research presented recently in the journal "ACS Macro Letters" shows that soldiers who suffer internal trauma from explosions may eventually be able to reap the benefits of a new treatment being developed.

Healthcare ETFs Continue to Perform Positively

ETF Trends released an article that covers the "indomitable run for the healthcare sector" — specifically, it looks at healthcare ETFs and why they are doing so well.

Read More Market News


See all Authors